New breast cancer subtype responds to drug
ST. LOUIS, March 3 (UPI) — U.S. cancer experts say they’ve found a newly identified cancer biomarker might define a new subtype of breast cancer and offer a potential way to treat it.
Read more on UPI
New breast cancer subtype responds to drug
Lung cancer drug response tied to tumor type: study
Lung cancer drug response tied to tumor type: study
Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial.
Read more on Reuters via Yahoo! News
Related posts
Experimental vaccine can help delay IBD and colon cancer
Experimental vaccine can help delay IBD and colon cancer
An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory bowel disease (IBD) and in turn prevent progression to colon cancer, according to researchers at the University of Pittsburgh School of Medicine.
Read more on News-Medical-Net